Related Experiment Video

Updated: Jul 14, 2026

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
09:44

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis

Published on: October 14, 2025

Challenges and progress in pediatric inflammatory bowel disease

Paul A Rufo1, Athos Bousvaros

  • 1Children's Hospital Boston, Inflammatory Bowel Disease Center, Boston, Massachusetts 02115, USA. paul.rufo@childrens.harvard.edu

Current Opinion in Gastroenterology
|June 5, 2007
PubMed

Insights

Recent advances offer improved diagnosis and treatment for pediatric inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease. New insights aid in managing IBD complications and enhancing children's quality of life.

Area of Science:

  • Pediatric Gastroenterology
  • Inflammatory Bowel Disease (IBD) Research
  • Childhood Digestive Health

Background:

  • Effective management of pediatric inflammatory bowel disease (IBD) focuses on achieving remission and preventing complications.
  • Recent research provides novel insights into the pathogenesis, epidemiology, and treatment of IBD in children.
  • These advancements support a more rational approach to diagnosing and treating pediatric ulcerative colitis and Crohn's disease.

Purpose of the Study:

  • To review current understanding and recent findings in pediatric inflammatory bowel disease.
  • To highlight new diagnostic and therapeutic strategies for children with ulcerative colitis and Crohn's disease.
  • To inform clinical practice for improved management of pediatric IBD.

Main Methods:

  • Review of population-based studies on pediatric IBD incidence.
  • Analysis of predictive factors for Crohn's disease complications.
  • Evaluation of emerging diagnostic tools (radiology, capsule endoscopy) and biological therapies.
  • Assessment of behavioral interventions' impact on pediatric IBD.

Main Results:

  • Confirmed increase in pediatric inflammatory bowel disease incidence.
  • Identified predictive value of medical history and serologies for Crohn's disease complications.
  • Highlighted potential of new radiological and endoscopic techniques for diagnosis and monitoring.
  • Emphasized the growing role of biological therapies and positive impact of behavioral interventions in managing pediatric IBD.
  • Demonstrated that behavioral interventions can positively influence morbidity and quality of life in children with IBD.

Conclusions:

  • New data on the natural history of Crohn's disease and ulcerative colitis enhance treatment strategies.
  • Improved understanding of diverse treatment modalities facilitates individualized care.
  • Future pharmacological treatment plans for pediatric IBD will be more effective and personalized.
Abstract

More Related Videos

Oral Gavage in Neonatal Mouse Pups and Functional Assessment of Gut Barrier Integrity Using Ussing Chambers07:18

Oral Gavage in Neonatal Mouse Pups and Functional Assessment of Gut Barrier Integrity Using Ussing Chambers

Published on: January 9, 2026

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...